FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Goetz

Research Profile

Disorders

Chemicals & Drugs

Occupations

Pharmacogenetics

Concepts & Ideas

Procedures

Physiology

Co-author Network

Publications

TOP 3
Mohan Liu; Yusuke Nakamura; Donald W Northfelt; Edith A Perez; Tracy L Pietrzak; Mark Robson; Daniel J Schaid; Liewei Wang; Anthony Batzler; Aman U Buzdar; Erin E Carlson; Brooke L Fridley; Matthew P Goetz; James N Ingle; Gregory D Jenkins; Michiaki Kubo; Clark V Williard; Richard M Weinshilboum
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
Matthew P Goetz
Update on CYP2D6 and Tamoxifen.
Matthew R Callstrom; J William Charboneau; Kirkland W Davis; Damian E Dupuy; Matthew P Goetz; Cheryl Hoffman; Peter J Littrup; Paul J Novotny; Ricardo Paz-Fumagalli; Joseph Rubin; Grant D Schmit; Thomas D Atwell; Robert A Beres; Kathy J Brown; Stephen B Solomon; Jeff A Sloan
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Goetz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mohan Liu; Yusuke Nakamura; Donald W Northfelt; Edith A Perez; Tracy L Pietrzak; Mark Robson; Daniel J Schaid; Liewei Wang; Anthony Batzler; Aman U Buzdar; Erin E Carlson; Brooke L Fridley; Matthew P Goetz; James N Ingle; Gregory D Jenkins; Michiaki Kubo; Clark V Williard; Richard M Weinshilboum
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
Molecular endocrinology (Baltimore, Md.) 2013;27(4):657-70.
2013: Matthew P Goetz
Update on CYP2D6 and Tamoxifen.
Clinical advances in hematology & oncology : H&O 2013;11(3):178-80.
2013: Matthew R Callstrom; J William Charboneau; Kirkland W Davis; Damian E Dupuy; Matthew P Goetz; Cheryl Hoffman; Peter J Littrup; Paul J Novotny; Ricardo Paz-Fumagalli; Joseph Rubin; Grant D Schmit; Thomas D Atwell; Robert A Beres; Kathy J Brown; Stephen B Solomon; Jeff A Sloan
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.
Cancer 2013;119(5):1033-41.
2013: Matthew P Goetz; Richard Greil; Tanya L Hoskin; Matthew M Ames; Otto Dietze; Martin Filipits; Michael Gnant; Raimund Jakesz; Mary Kuffel; Alois Lang; Felix Offner; Carol A Reynolds; Margaretha Rudas; Stephanie L Safgren; Vera J Suman; Richard M Weinshilboum; James N Ingle
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(2):500-7.
2013: John Hawse; James N Ingle; Wilma L Lingle; Kevin S Pitel; Mine S Cicek; Anne Gingery; Matthew P Goetz; Sarah B Grygo; Malayannan Subramaniam; Zhifu Sun; Xianglin Wu; Thomas C Spelsberg
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens.
PloS one 2013;8(1):e54613.
2012: Shernan G Holtan; Fabiola Medeiros; Stephanie L Safgren; Preston D Steen; Matthew M Ames; Robert J Behrens; Charles Erlichman; Nathan R Foster; David Graham; Matthew P Goetz
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.
PloS one 2012;7(7):e39285.
2011: Ann M Moyer; Stephanie L Safgren; Vera J Suman; Richard M Weinshilboum; Matthew M Ames; Rajeswari Avula; John L Black; James N Ingle; Mary J Kuffel; Matthew P Goetz
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
Pharmacogenomics 2011;12(11):1535-43.
2011: Peter P Stanich; Victoria L Owens; Seth Sweetser; Sherezade Khambatta; Thomas C Smyrk; Ronald L Richardson; Matthew P Goetz; Mrinal M Patnaik
Colonic polyposis and neoplasia in Cowden syndrome.
Mayo Clinic proceedings. Mayo Clinic 2011;86(6):489-92.
2011: Xianglin Wu; Matthew P Goetz; Sarah B Grygo; James N Ingle; Wilma L Lingle; Vivian C Negron; Thomas C Spelsberg; Malayannan Subramaniam; Zhifu Sun; John Hawse
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Breast cancer research : BCR 2011;13(2):R27.
2010: James N Ingle; Daniel J Schaid; Paul E Goss; Mohan Liu; Taisei Mushiroda; Judy-Anne W Chapman; Michiaki Kubo; Gregory D Jenkins; Anthony Batzler; Lois Shepherd; Joseph Pater; Liewei Wang; Matthew J Ellis; Vered Stearns; Daniel C Rohrer; Matthew P Goetz; Kathleen I Pritchard; David A Flockhart; Yusuke Nakamura; Richard M Weinshilboum
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4674-82.
2010: Matthew P Goetz
Update on CYP2D6 and its impact on tamoxifen therapy.
Clinical advances in hematology & oncology : H&O 2010;8(8):536-8.
2010: Kathryn E Reinicke; Mary J Kuffel; Matthew P Goetz; Matthew M Ames
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells.
Cancer chemotherapy and pharmacology 2010;66(3):575-83.
2010: James N Ingle; Aman U Buzdar; Daniel J Schaid; Matthew P Goetz; Anthony Batzler; Mark Robson; Donald W Northfelt; Janet E Olson; Edith A Perez; Zeruesenay Desta; Randy A Weintraub; Clark V Williard; David A Flockhart; Richard M Weinshilboum
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
Cancer research 2010;70(8):3278-86.
2010: Sejal S Shah; Rhett P Ketterling; Matthew P Goetz; James N Ingle; Carol A Reynolds; Edith A Perez; Beiyun Chen
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.
Human pathology 2010;41(1):103-6.
2009: Matthew P Goetz
Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factor.
Oncology (Williston Park, N.Y.) 2009;23(14):1233-4, 1236.
2009: Rajini Katipamula; Amy C Degnim; Tanya L Hoskin; Judy C Boughey; Charles L Loprinzi; Clive S Grant; Kathleen R Brandt; Sandhya Pruthi; Christopher G Chute; Janet E Olson; Fergus J. Couch; James N Ingle; Matthew P Goetz
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4082-8.
2009: Xianglin Wu; John Hawse; Malayannan Subramaniam; Matthew P Goetz; James N Ingle; Thomas C Spelsberg
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.
Cancer research 2009;69(5):1722-7.
2009: Matthew P Goetz; Matthew M Ames; M Weinshilboum; James N Ingle
Endocrine therapy in 2009: consideration of the tumor and the host.
Oncology (Williston Park, N.Y.) 2009;23(2):150-1, 154.
2009: Tow S Tan; Tamana Walia; Eva Galanis; Matthew P Goetz; Joseph Rubin; Aminah Jatoi
If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees.
Journal of cancer education : the official journal of the American Association for Cancer Education 2009;24(3):200-3.
2008: Matthew P Goetz; Vera J Suman; Fergus J. Couch; Matthew M Ames; James M Rae; Mark G Erlander; Xiao-Jun Ma; Dennis C Sgroi; Carol A Reynolds; Wilma L Lingle; Richard M Weinshilboum; David A Flockhart; Zeruesenay Desta; Edith A Perez; James N Ingle
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5864-8.
2008: Judith A Gilbert; Matthew P Goetz; Carol A Reynolds; James N Ingle; Karin F Giordano; Vera J Suman; Hilary E Blair; Robert B Jenkins; Wilma L Lingle; Monica M Reinholz; Alex A. Adjei; Matthew M Ames
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
Molecular cancer therapeutics 2008;7(4):944-51.
2008: Matthew P Goetz; A Kamal; Matthew M Ames
Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.
Clinical pharmacology and therapeutics 2008;83(1):160-6.
2007: Sandhya Pruthi; Judy C Boughey; Kathleen R Brandt; Amy C Degnim; Grace K Dy; Matthew P Goetz; Edith A Perez; Carol A Reynolds; Paula J Schomberg; James N Ingle
A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.
Mayo Clinic proceedings. Mayo Clinic 2007;82(9):1131-40.
2007: Sandhya Pruthi; Kathleen R Brandt; Amy C Degnim; Matthew P Goetz; Edith A Perez; Carol A Reynolds; Paula J Schomberg; Grace K Dy; James N Ingle
A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis.
Mayo Clinic proceedings. Mayo Clinic 2007;82(8):999-1012.
2007: Steven R Alberts; George P Kim; Michelle R Mahoney; Michael K Gornet; Joseph Rubin; Matthew Ames; Matthew P Goetz; Richard M Weinshilboum; Steven J Nicol; Richard M Goldberg
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
Clinical colorectal cancer 2007;6(8):572-7.
2007: Robert R McWilliams; Matthew P Goetz; Bruce W Morlan; Muhammad Salim; Kendrith M Rowland; James E Krook; Matthew M Ames; Charles Erlichman
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
Clinical colorectal cancer 2007;6(7):516-21.
2007: Matthew P Goetz; James N Ingle; Fergus J. Couch
Gene-expression-based predictors for breast cancer.
The New England journal of medicine 2007;356(7):752; author reply 752-3.
2007: Matthew P Goetz; Stacey K Knox; Vera J Suman; James M Rae; Stephanie L Safgren; Matthew M Ames; Daniel W Visscher; Carol Reynolds; Fergus J. Couch; Wilma L Lingle; Richard M Weinshilboum; Emily G Barr Fritcher; Andrea M Nibbe; Zeruesenay Desta; Anne Nguyen; David A Flockhart; Edith A Perez; James N Ingle
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.
Breast cancer research and treatment 2007;101(1):113-21.
2006: James N Ingle; Vera J Suman; James A Mailliard; John W Kugler; James E Krook; John C Michalak; Thomas M Pisansky; Lester E Wold; John H Donohue; Matthew P Goetz; Edith A Perez
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
Breast cancer research and treatment 2006;98(2):217-22.
2006: Matthew P Goetz; Vera J Suman; James N Ingle; Andrea M Nibbe; Daniel W Visscher; Carol A Reynolds; Wilma L Lingle; Mark G Erlander; Xiao-Jun Ma; Dennis C Sgroi; Edith A Perez; Fergus J. Couch
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2080-7.
2005: Matthew P Goetz; James M Rae; Vera J Suman; Stephanie L Safgren; Matthew M Ames; Daniel W Visscher; Carol Reynolds; Fergus J. Couch; Wilma L Lingle; David A Flockhart; Zeruesenay Desta; Edith A Perez; James N Ingle
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9312-8.
2005: Matthew P Goetz; David O Toft; Joel Reid; Matthew Ames; Bridget Stensgard; Stephanie L Safgren; Alex A. Adjei; Jeff Sloan; Pamela J Atherton; Vlad Vasile; Sandra Salazaar; Alex Adjei; Gary A Croghan; Charles Erlichman
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1078-87.
2005: James M Rae; Matthew P Goetz; Daniel F Hayes; James N Ingle; Lang Li; Anna Maria Storniolo; Vered Stearns; David A Flockhart
CYP2D6 genotype and tamoxifen response.
Breast cancer research : BCR 2005;7(5):E6.
2004: Matthew P Goetz; Matthew M Ames; Richard M Weinshilboum
Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
Mayo Clinic proceedings. Mayo Clinic 2004;79(3):376-84.
2003: Matthew P Goetz; Charles Erlichman; Anthony J Windebank; Joel M Reid; Jeff A Sloan; Pamela J Atherton; Alex A. Adjei; Joseph Rubin; Henry C Pitot; Evanthia C Galanis; Matthew M Ames; Richard M Goldberg
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3761-9.
2003: Matthew P Goetz; David O Toft; Matthew M Ames; Charles Erlichman
The Hsp90 chaperone complex as a novel target for cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1169-76.